REVB
Price
$0.40
Change
-$0.01 (-2.44%)
Updated
Jan 17 closing price
Capitalization
3.34M
TELIF
Price
$0.28
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
14.91M
Ad is loading...

REVB vs TELIF

Header iconREVB vs TELIF Comparison
Open Charts REVB vs TELIFBanner chart's image
Revelation Biosciences
Price$0.40
Change-$0.01 (-2.44%)
Volume$357.81K
Capitalization3.34M
TELESCOPE INNOVATIONS
Price$0.28
Change-$0.00 (-0.00%)
Volume$2.5K
Capitalization14.91M
REVB vs TELIF Comparison Chart
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. TELIF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a Hold and TELIF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (REVB: $0.40 vs. TELIF: $0.28)
Brand notoriety: REVB and TELIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 9% vs. TELIF: 20%
Market capitalization -- REVB: $3.34M vs. TELIF: $14.91M
REVB [@Biotechnology] is valued at $3.34M. TELIF’s [@Biotechnology] market capitalization is $14.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green whileTELIF’s FA Score has 0 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • TELIF’s FA Score: 0 green, 5 red.
According to our system of comparison, REVB is a better buy in the long-term than TELIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 4 TA indicator(s) are bullish while TELIF’s TA Score has 3 bullish TA indicator(s).

  • REVB’s TA Score: 4 bullish, 5 bearish.
  • TELIF’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, REVB is a better buy in the short-term than TELIF.

Price Growth

REVB (@Biotechnology) experienced а -24.34% price change this week, while TELIF (@Biotechnology) price change was -4.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

REVB is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TELIF($14.9M) has a higher market cap than REVB($3.34M). TELIF YTD gains are higher at: 6.480 vs. REVB (-13.210). TELIF has higher annual earnings (EBITDA): -436.22K vs. REVB (-8.52M). REVB has more cash in the bank: 6.54M vs. TELIF (374K). REVB has less debt than TELIF: REVB (0) vs TELIF (2.02M). TELIF has higher revenues than REVB: TELIF (3.9M) vs REVB (0).
REVBTELIFREVB / TELIF
Capitalization3.34M14.9M22%
EBITDA-8.52M-436.22K1,953%
Gain YTD-13.2106.480-204%
P/E RatioN/A85.38-
Revenue03.9M-
Total Cash6.54M374K1,749%
Total Debt02.02M-
TECHNICAL ANALYSIS
Technical Analysis
REVBTELIF
RSI
ODDS (%)
Bearish Trend 12 days ago
71%
Bearish Trend 12 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
64%
Bearish Trend 12 days ago
64%
Momentum
ODDS (%)
Bullish Trend 12 days ago
54%
Bullish Trend 12 days ago
81%
MACD
ODDS (%)
Bullish Trend 12 days ago
47%
Bullish Trend 12 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
57%
Bearish Trend 12 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
46%
Bearish Trend 12 days ago
47%
Advances
ODDS (%)
Bullish Trend 18 days ago
70%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
69%
Bearish Trend 12 days ago
64%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
66%
View a ticker or compare two or three
Ad is loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASPZX31.670.39
+1.25%
Alger Spectra Z
LGCYX16.960.14
+0.83%
Lord Abbett Global Equity I
FNFPX63.200.40
+0.64%
American Funds New Perspective 529-F-3
MLVPX18.890.04
+0.21%
MFS Low Volatility Equity R3
NRIFX21.400.02
+0.09%
Nuveen Real Asset Income R6

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-3.45%
GNPX - REVB
48%
Loosely correlated
+2.86%
TCRT - REVB
46%
Loosely correlated
+4.05%
TOVX - REVB
31%
Poorly correlated
+3.50%
TSHA - REVB
31%
Poorly correlated
-3.16%
CVKD - REVB
28%
Poorly correlated
-4.40%
More

TELIF and

Correlation & Price change

A.I.dvisor tells us that TELIF and ATNM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELIF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELIF
1D Price
Change %
TELIF100%
+0.36%
ATNM - TELIF
31%
Poorly correlated
+14.75%
RVXCF - TELIF
22%
Poorly correlated
N/A
ENTX - TELIF
20%
Poorly correlated
+4.93%
ACUT - TELIF
11%
Poorly correlated
-7.01%
REVB - TELIF
9%
Poorly correlated
-3.45%
More